000 01442 a2200421 4500
005 20250513105109.0
264 0 _c19970225
008 199702s 0 0 eng d
022 _a0098-6577
040 _aNLM
_beng
_cNLM
100 1 _aZiai, F
245 0 0 _aThe angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
_h[electronic resource]
260 _bKidney international. Supplement
_cDec 1996
300 _aS132-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiotensin Receptor Antagonists
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aBiphenyl Compounds
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aEnalapril
_xpharmacology
650 0 4 _aIrbesartan
650 0 4 _aKidney Failure, Chronic
_xdrug therapy
650 0 4 _aKidney Glomerulus
_xdrug effects
650 0 4 _aNephrectomy
650 0 4 _aProteinuria
_xprevention & control
650 0 4 _aRats
650 0 4 _aRats, Inbred SHR
650 0 4 _aTetrazoles
_xpharmacology
700 1 _aOts, M
700 1 _aProvoost, A P
700 1 _aTroy, J L
700 1 _aRennke, H G
700 1 _aBrenner, B M
700 1 _aMackenzie, H S
773 0 _tKidney international. Supplement
_gvol. 57
_gp. S132-6
999 _c8934254
_d8934254